Loading
Latest filing published 17 Aug 2026 for Candel Therapeutics, Inc., €71k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Seshu Tyagarajan has a single filing on record, published on 17 August 2026: a transaction of €71k in Candel Therapeutics, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration